Free Trial
NASDAQ:HSTO

Histogen (HSTO) Stock Price, News & Analysis

Histogen logo
$0.0003 0.00 (0.00%)
As of 07/24/2025

About Histogen Stock (NASDAQ:HSTO)

Key Stats

Today's Range
$0.0003
$0.0003
50-Day Range
$0.00
$0.04
52-Week Range
$0.05
$0.55
Volume
569 shs
Average Volume
10,369 shs
Market Capitalization
$1.28 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HSTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Histogen and its competitors with MarketBeat's FREE daily newsletter.

HSTO Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Histogen Files For Voluntary Chapter 11 Bankruptcy Protection
See More Headlines

HSTO Stock Analysis - Frequently Asked Questions

Histogen's stock was trading at $0.0250 on January 1st, 2025. Since then, HSTO shares have decreased by 98.8% and is now trading at $0.0003.

Histogen Inc. (NASDAQ:HSTO) released its quarterly earnings results on Wednesday, November, 10th. The company reported ($1.80) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.20) by $0.40. The business earned $0.59 million during the quarter.

Histogen shares reverse split on the morning of Friday, June 3rd 2022.The 1-20 reverse split was announced on Friday, June 3rd 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, June 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of HSTO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Histogen investors own include Tesla (TSLA), Bionano Genomics (BNGO), Applied Genetic Technologies (AGTC), HubSpot (HUBS), Meta Platforms (META) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/10/2021
Today
7/25/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HSTO
CIK
1383701
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$19 thousand
Price / Sales
0.07
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.13 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
4,270,000
Free Float
N/A
Market Cap
$1.28 thousand
Optionable
Not Optionable
Beta
1.19
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:HSTO) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners